INBICON A/S: Financial statements 2018
CVR: 27036635
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
INBICON A/S (CVR 27036635) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -16,269,000 and a net result of DKK -12,699,000 compared with DKK -7,621,000 the year before. Equity in the 2018 report amounted to DKK 8,809,000. The solvency ratio was 49.5%.
- Gross Profit
- DKK -16,269,000
- Profit/Loss
- DKK -12,699,000
- Equity
- DKK 8,809,000
- Total Assets
- DKK 17,803,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -16.3 mio. | -12.7 mio. | 8.8 mio. | - |
| 2017 | - | -4.4 mio. | -7.6 mio. | 21.5 mio. | - |
| 2016 | - | -13.8 mio. | -16.8 mio. | 47.1 mio. | - |
| 2015 | - | -43.2 mio. | -35.1 mio. | 63.9 mio. | - |
| 2014 | 14 mio. | -61.4 mio. | -45.4 mio. | 59 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
INBICON A/S has published its annual report for 2017. Gross profit came to DKK -4,419,000, and the net result was DKK -7,621,000.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.